A 14 mg oral dose of semaglutide is roughly comparable to 0.5 mg injectable , though switching may not be suitable for patients on higher doses
Newer medicine options, including the sodium-glucose cotransport 2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists, have been shown to protect the heart and reduce the risk of many specific heart-related outcomes for people with type 2 diabetes
Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose
Affected individuals present with acute encephalopathy, hypotonia, and seizures associated with acute loss of motor skills and dystonia, rigidity, and spasticity [48,49,50]
The effects of liraglutide on liver enzymes and metabolic factors in patients with nonalcoholic steatohepatitis: a meta-analysis of randomized controlled trials